Biotechnology ETF List

Ticker SymbolNameIssuerCategoryMarket CapYieldExpense RatioLast Price30 Day Change %Description
ARKGARK Genomic Revolution ETFARKActive Equity$1,843,405,0000.00%0.75%$13.4011.48%The fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors.
BBCVirtus LifeSci Biotech Clinical Trials ETFVirtus Investment PartnersPassive Equity$9,088,5510.00%0.79%$21.524.26%The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index.
BBHVanEck Biotech ETFVanEckPassive Equity$445,047,6860.49%0.35%$161.701.25%Seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR).
BBPVirtus LifeSci Biotech Products ETFVirtus Investment PartnersPassive Equity$15,660,2090.00%0.79%$52.845.86%Seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index.
BIBProShares Ultra Nasdaq BiotechnologyProSharesPassive Equity$76,716,7500.04%0.95%$51.691.70%Seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.
BISProShares UltraShort Nasdaq BiotechnologyProSharesPassive Equity$4,453,4310.62%0.95%$20.91-2.24%Seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index.
BTECPrincipal Healthcare Innovators ETFPrincipalActive Equity$42,291,9310.00%0.42%$32.277.75%Seeks to tap into the increasing demand for healthcare solutions as demographic trends have driven healthcare spending to more than double in the last 20 years.1
FBTFirst Trust NYSE Arca Biotechnology Index FundFirst TrustPassive Equity$1,183,627,7870.00%0.55%$153.292.23%Exchange-traded index fund. The investment objective of the Fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index.
GNOMGlobal X Genomics & Biotechnology ETFGlobal XEquity$95,658,0000.00%0.50%$11.059.18%Seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology
IBBiShares BiotechnologyBlackrockPassive Equity$6,608,140,0000.26%0.44%$127.582.35%The iShares Biotechnology ETF Seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
IDNAiShares Genomics Immunology and Healthcare ETFBlackrockPassive Equity$121,325,0000.34%0.47%$21.928.43%Seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
LABDDirexion Daily S&P Biotech Bear 3x SharesDirexionPassive Equity$53,515,4113.26%0.96%$16.76-26.05%Seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will meet their stated investment objectives.
LABUDirexion Daily S&P Biotech Bull 3x SharesDirexionPassive Equity$1,059,288,7200.05%0.96%$4.8424.26%Seeks to replicate 300% of the daily performance of its benchmark, the S&P Biotechnology Select Industry Index.
PBEInvesco Dynamic Biotechnology & Genome ETFInvescoPassive Equity$233,023,0500.02%0.59%$60.856.30%Based on the Dynamic Biotech & Genome Intellidex℠ Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index.
SBIOALPS Medical Breakthroughs ETFSS&CPassive Equity$85,972,3330.00%0.50%$29.483.51%Seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
HELXFranklin Genomic Advancements EFranklinActive Equity$11,248,2400.00%0.50%$30.144.14%The Franklin Genomic Advancements ETF (HELX) is an actively managed fund that invests in companies that stand to benefit from advancements in genomic-based research techniques and technologies.
XDNAKelly CRISPR & Gene Editing Technology ETFKelly Intelligence LLCPassive Equity$00.00%0.78%$8.200.00%Seeks to provide total return by investing in a passively managed, concentrated portfolio of companies that engage in CRISPR & gene editing technology activities.
PSILAdvisorShares Psychedelics ETFAdvisorSharesActive Equity$5,985,0000.25%1.00%$1.64-10.74%PSIL is actively managed to provide exposure to the emerging global psychedelics industry.
WDNAWisdomTree BioRevolution FundWisdomTreeActive Equity$2,480,0000.42%0.45%$17.455.30%The WisdomTree BioRevolution Fund seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index .
IZRLARK Israel Innovative Technology ETFARKActive Equity$92,565,0000.00%0.49%$19.098.26%IZRL tracks an equally weighted index of Israeli companies causing advancements in the areas of genomics, health care, biotechnology, industrials, manufacturing, and IT.
XBISPDR S&P Biotech ETFState Street Global AdvisorsActive Equity$6,341,588,4000.00%0.35%8.91%Seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select IndustryTM Index (the “Index”)
CNCRRange Cancer TherapeuticsExchange Traded ConceptsPassive Equity$11,668,8140.00%0.79%$12.095.70%The Fund seeks to track the total return performance of the Range Cancer Therapeutics Index.